These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11021755)

  • 1. The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow.
    Turner SD; Rafferty JA; Fairbairn LJ; Ashby J; Tinwell H; Eckert HG; Baum C; Lashford LS
    Leukemia; 2000 Oct; 14(10):1796-802. PubMed ID: 11021755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses.
    Ashby J; Tinwell H; Glover P; Poorman-Allen P; Krehl R; Callander RD; Clive D
    Environ Mol Mutagen; 1994; 24(1):51-60. PubMed ID: 8050416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual effect of curcumin on etoposide action in leukemic and healthy bone marrow cells of rats with acute myeloid leukemia.
    Papiez MA; Krzyściak W
    Folia Med Cracov; 2014; 54(2):71-9. PubMed ID: 25648312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic risk assessment of etoposide from mouse bone marrow.
    Choudhury RC; Palo AK; Sahu P
    J Appl Toxicol; 2004; 24(2):115-22. PubMed ID: 15052606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of single/multiple-dose protocols using triethylenemelamine and procarbazine hydrochloride for the mouse bone marrow micronucleus test.
    Romagna F; Schneider BM
    Mutat Res; 1990; 234(3-4):169-78. PubMed ID: 2366786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues in mutagenesis and carcinogenesis, No. 55. Activity of etoposide in the mouse bone marrow micronucleus test: independence of route of exposure.
    Ashby J; Tinwell H
    Mutat Res; 1995 May; 328(2):243-44. PubMed ID: 7739607
    [No Abstract]   [Full Text] [Related]  

  • 7. Assays to predict the genotoxicity of the chromosomal mutagen etoposide -- focussing on the best assay.
    Turner SD; Wijnhoven SW; Tinwell H; Lashford LS; Rafferty JA; Ashby J; Vrieling H; Fairbairn LJ
    Mutat Res; 2001 Jun; 493(1-2):139-47. PubMed ID: 11516723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin.
    Lee CK; Ki SH; Choi JS
    Biopharm Drug Dispos; 2011 May; 32(4):245-51. PubMed ID: 21506134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etoposide: specificity of prolonged oral administration].
    Munck JN
    Bull Cancer; 1996 May; 83(5):352-60. PubMed ID: 8680087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of micronuclei frequency by vindesine in mouse bone marrow.
    Jagetia GC; Jyothi P
    Mutat Res; 1997 Jan; 388(1):1-5. PubMed ID: 9025786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in PtdIns(4,5)P2 induced by etoposide treatment modulates small intestinal P-glycoprotein via radixin.
    Kobori T; Harada S; Nakamoto K; Tokuyama S
    Biol Pharm Bull; 2014; 37(7):1124-31. PubMed ID: 24989004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of a multiple dosing protocol for the mouse bone-marrow micronucleus assay using benzidine and 2,6-xylidine.
    Parton JW; Beyers JE; Garriott ML; Tamura RN
    Mutat Res; 1990; 234(3-4):165-8. PubMed ID: 2366785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection.
    Hegewisch-Becker S; Hanania EG; Fu S; Körbling M; Deisseroth AB; Andreeff M
    Br J Haematol; 1995 Aug; 90(4):876-83. PubMed ID: 7669666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the clastogenic effect of cyclophosphamide by WR-2721 in the bone marrow of mice.
    Mazur L; Czyzewska A
    Mutat Res; 1994 Sep; 309(2):219-23. PubMed ID: 7520979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide and etoposide canine studies demonstrate the cross-species potential of the flow cytometric peripheral blood micronucleated reticulocyte endpoint.
    McKeon M; Xu Y; Kirkland D; Schmuck G; Krebsfänger N; Avlasevich SL; Dertinger SD
    Mutat Res; 2012 Feb; 742(1-2):79-83. PubMed ID: 22227404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated-dose liver and gastrointestinal tract micronucleus assays with CI Solvent Yellow 14 (Sudan I) using young adult rats.
    Matsumura S; Ikeda N; Hamada S; Ohyama W; Wako Y; Kawasako K; Kasamatsu T; Nishiyama N
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Mar; 780-781():76-80. PubMed ID: 25892626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane.
    Attia SM; Al-Anteet AA; Al-Rasheed NM; Alhaider AA; Al-Harbi MM
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):837-45. PubMed ID: 19184016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells.
    Chinnasamy N; Fairbairn LJ; Laher J; Willington MA; Rafferty JA
    Mutat Res; 1998 Aug; 416(1-2):1-10. PubMed ID: 9725988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of N-acetylcysteine to protect the mouse bone marrow against the clastogenicity of 7,12-dimethylbenzanthracene.
    Doyle CE; Mackay JM; Ashby J
    Mutagenesis; 1993 Nov; 8(6):583-4. PubMed ID: 8133789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of benzene-induced genotoxicity in mice by indomethacin.
    Pirozzi SJ; Renz JF; Kalf GF
    Mutat Res; 1989 Mar; 222(3):291-8. PubMed ID: 2922013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.